Advertisement

Topics

Companies Related to "Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions" [Most Relevant Company Matches] RSS

04:31 EST 25th November 2017 | BioPortfolio

Here are the most relevant search results for "Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions" found in our extensive corporate database of over 50,000 company records.

Showing "Autologous Cell derived Tissue Engineered Cartilage Repairing Articular" Companies 1–25 of 2,200+

Extremely Relevant

Histogenics Corp.

Histogenics is a leading regenerative medicine company that combines cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration. In May of 2011, Histogenics acquired Israeli cell-therapy company ProChon BioTech. Histogenics’ flagship products focus on the treatment of active patients suffe...


Orthocell Limited

Orthocell is a commercial-stage, regenerative medicine company focused on regenerating mobility for patients and our ageing population by developing products for a variety of tendon, cartilage and soft tissue injuries. Orthocell’s portfolio of products include TGA-approved stem cell therapies Autologous Tenocyte Implantation (Ortho-ATI™) and Auto...

C3

Clinical Cell Culture (C3) is a company listed on the Australian Stock Exchange (ASX Code CCE) that was established to commercialise a number of autologous tissue engineered products for autologous cell replacement.C3 is able to provide culture services from laboratories based in Australia and Europe and is expanding their sales, marketing and clinical support programme throughout the world. This ...


Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune ...

BioTissue Technologies GmbH

BioTissue Technologies is a pioneer in the biotechnology field of tissue engineering. For over seven years we have been developing and producing "autologous tissue replacements" to restore missing or damaged bone or cartilage tissue.

Ars Arthro AG

The autologous cartilage transplant CaReSâ„¢ - Cartilage Repair System - offered by ARS ARTHRO AG is a 3D mechanically stable transplant based on patientspecific autologous cartilage cellls and a unique patent pending collagen matrix.Based on the present state of art, the Ars Arthro transplant is the only product with all of the following characteristics: easily adaptable intraoperatively to f...

U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell-based therapies that prevent or treat disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

Relevant

ARS ARTHRO AG®

The autologous cartilage transplant CaReS® - Cartilage Regeneration System - offered by ARS ARTHRO AG® is a 3D mechanically stable transplant based on patient specific autologous cartilage cells and a unique patent pending collagen matrix.Based on the present state of art, the ARS ARTHRO AG® transplant is the only product that is easily adaptable intra-operatively to fit the defect, it offers c...

Advanced Tissue Sciences Incorporated

Founded in 1987, Advanced Tissue Sciences (ATIS) has developed a technology to manufacture human-based tissues and organs for repair and transplantation. Focusing mainly on the therapeutic products, the Company's technologies have broad applications throughout the traditional healing and transplant markets. Advanced Tissue Sciences is focusing on two cell types, fibroblasts (connective tissue cell...

Core Dynamics Inc.

Core Dynamics is a privately held biotechnology company that is stretching the horizons of the science of cryopreservation. The company is active in the research and development of unique freezing, thawing and freeze drying technologies that are being applied in work with cell preservation, blood transfusion, and tissue and organ transplantation. The company has developed unique protocols, equ...

BrainStorm Cell Therapeutics, Inc.

BrainStorm Cell Therapeutics Inc. is a promising company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The Company holds rights to develop and commercialize the technology through an exclusive, worldwide licensing agreement with Ramot at Tel Aviv Universit...

Advanced Tissue Sciences

Advanced Tissue Sciences, Inc. is a leading tissue engineering company engaged in the development of human-based tissue products for therapeutic applications. The Company is currently focusing its efforts primarily on skin, cartilage and cardiovascular products. Utilizing principles of cell biology, bioengineering, biochemistry, and polymer and transplant science, the Company has developed and i...

TissueGene

Starting in 1997, the founders of TissueGene sought to uncover different surgical and gene-based therapeutics for a variety of arthritic conditions. The diligence soon paid off in the form of the first successful animal model for cartilage repair. Subsequently, in the middle of 1999, TissueGene, Inc was incorporated in the United States. TissueGene's initial findings resulted in the focused develo...

Cytori Therapeutics Inc.

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied acro...

Tissue Genesis, Inc.

An emerging leader in adipose-derived cell therapy and regenerative medicine, Tissue Genesis, Inc. is a high-growth, clinical-stage company based in Honolulu, Hawai‘i. Industry-leading engineers and scientists have developed a proprietary process for Tissue Genesis that may deliver innovative medical solutions for a wide range of existing medical prob...

Ankasa Regenerative Therapeutics, Inc.

Ankasa Regenerative Therapeutics is a biopharmaceutical company developing strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The Company is developing proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bo...

CardioMend

CardioMend’s heart valve technology is designed to avoid the problems associated with current replacement heart valves, whether mechanical, animal tissue, or human cadaver tissue. Mechanical valves, while durable, require patients to be on lifelong daily anti-coagulation (blood thinning) medication to reduce the risk of blood clotting that might otherwise occur. Animal and cadaver tissue valve...

BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is an emerging company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The patent pending technology is based on discoveries made by the scientific team led by Professor Eldad Melamed, former Head of Neurology at Rabin Medic...

Kite Pharma Inc.

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the development of novel cancer immunotherapeutic products, with focus on engineered autologous T cell therapeutics targeted to different tumor types. Kite is based in Los Angeles, CA. For more information, visit the company’s website at www.kitepharma.com.

Celartia

Celartia applies scientific reasoning and sound engineering to transform the art of cell culture into a reproducible science.Celartia improves its customers’ ability to systematically develop cells and their engineered byproducts for use in solving today’s toughest challenges in medical, pharmaceutical, educational, environmental, and defense applications. Celartia achieves that result by deli...

Stratatech Corporation

Stratatech Corp. is a privately-held regenerative medicine company focused on the development and commercialization of cell-based, tissue-engineered skin substitute products for therapeutic and research applications. These products are made using the company’s proprietary NIKS® cells – a human keratinocyte progenitor cell line that faithfully ...

StemSource Incorporated

Stem cells are uniquely "unprogrammed" cells that give rise to all other cells in our bodies. They are important because they offer a potential source of replacement cells and tissues that are able to treat a myriad of disorders including neurologic diseases such as Parkinson's, Alzheimer's, spinal cord injury, and stroke, tissue loss or injury, heart disease, diabetes and arthritis.Millions of Am...

Fate Therapeutics Inc.

Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation’s research hotbeds (Boston, San Francisco, San Diego and Seattle) who have demonstrated the potential to create and modulate st...

CryoLife Inc.

Founded in 1984, CryoLife was the first company to commercially develop the ultra-low temperature preservation of viable human heart valves for transplant. Since then, we have been engaged in an exciting transfer of technology which has led to the highly successful preservation of human saphenous and femoral veins as well as orthopaedic tissues such as tendons, menisci, and osteo-articular cartila...

Osiris Therapeutics

Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues. The next revolution in medical care Osiris Therapeutics is commercializing products from a readily available and non-controversial source – adult bone marrow. These st...


More From BioPortfolio on "Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions"

Quick Search
Advertisement
 

Corporate Database Quicklinks